BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30060554)

  • 21. Oral-lung microbiome interactions in lung diseases.
    Mammen MJ; Scannapieco FA; Sethi S
    Periodontol 2000; 2020 Jun; 83(1):234-241. PubMed ID: 32385873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Dietary Nutrients in Inflammatory Bowel Disease.
    Sugihara K; Morhardt TL; Kamada N
    Front Immunol; 2018; 9():3183. PubMed ID: 30697218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of the respiratory tract microbiota in cystic fibrosis.
    de Koff EM; de Winter – de Groot KM; Bogaert D
    Curr Opin Pulm Med; 2016 Nov; 22(6):623-8. PubMed ID: 27583669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging pathogenic links between microbiota and the gut-lung axis.
    Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM
    Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Host Microbiota Contributes to Early Protection Against Lung Colonization by
    Dumas A; Corral D; Colom A; Levillain F; Peixoto A; Hudrisier D; Poquet Y; Neyrolles O
    Front Immunol; 2018; 9():2656. PubMed ID: 30487801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.
    Bhagirath AY; Li Y; Somayajula D; Dadashi M; Badr S; Duan K
    BMC Pulm Med; 2016 Dec; 16(1):174. PubMed ID: 27919253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenic role of the gut microbiota in gastrointestinal diseases.
    Nagao-Kitamoto H; Kitamoto S; Kuffa P; Kamada N
    Intest Res; 2016 Apr; 14(2):127-38. PubMed ID: 27175113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.
    Chen WX; Ren LH; Shi RH
    World J Gastroenterol; 2014 Nov; 20(42):15657-63. PubMed ID: 25400449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of the respiratory tract microbiota in cystic fibrosis.
    de Koff EM; Groot KM; Bogaert D
    Curr Opin Pulm Med; 2016 Nov; 22(6):623-628. PubMed ID: 27841789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases.
    Grigg JB; Sonnenberg GF
    J Immunol; 2017 Jan; 198(2):564-571. PubMed ID: 28069751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of microbiota on lung homeostasis and diseases.
    Wang J; Li F; Tian Z
    Sci China Life Sci; 2017 Dec; 60(12):1407-1415. PubMed ID: 29019144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host-microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease.
    Gosens R; Hiemstra PS; Adcock IM; Bracke KR; Dickson RP; Hansbro PM; Krauss-Etschmann S; Smits HH; Stassen FRM; Bartel S
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32430415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbiome and its role in cardiovascular diseases.
    Ahmadmehrabi S; Tang WHW
    Curr Opin Cardiol; 2017 Nov; 32(6):761-766. PubMed ID: 29023288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
    Satokari R
    Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host-microbial Cross-talk in Inflammatory Bowel Disease.
    Nagao-Kitamoto H; Kamada N
    Immune Netw; 2017 Feb; 17(1):1-12. PubMed ID: 28261015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases.
    Chellappan DK; Sze Ning QL; Su Min SK; Bin SY; Chern PJ; Shi TP; Ee Mei SW; Yee TH; Qi OJ; Thangavelu L; Rajeshkumar S; Negi P; Chellian J; Wadhwa R; Gupta G; Collet T; Hansbro PM; Dua K
    Chem Biol Interact; 2019 Sep; 310():108732. PubMed ID: 31276660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NSAID-Gut Microbiota Interactions.
    Maseda D; Ricciotti E
    Front Pharmacol; 2020; 11():1153. PubMed ID: 32848762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The microbiome in respiratory medicine: current challenges and future perspectives.
    Faner R; Sibila O; Agustí A; Bernasconi E; Chalmers JD; Huffnagle GB; Manichanh C; Molyneaux PL; Paredes R; Pérez Brocal V; Ponomarenko J; Sethi S; Dorca J; Monsó E
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of the Mucosal Microbiota to Bovine Respiratory Health.
    Zeineldin M; Lowe J; Aldridge B
    Trends Microbiol; 2019 Sep; 27(9):753-770. PubMed ID: 31104970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.